Manufacture

What separates a good model from a bad model in bioprocess development?

What was hot in 2016? And what should pharma's priorities lie in 2017?

We investigate the advantages and limitations of microcalorimetry in biopharma.

Our infographic shows the huge disconnect between patients and drug manufacturers.

Could public health suffer if the pharma industry doesn’t learn to win back trust?

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

Data, data everywhere… But pharma is not making the most out of it.

A surge of exciting new cell-based treatments is coming – but is the industry ready?

What do ISPE’s 2016 Facility of the Year Awards tell us about the future direction of the industry?

One year on from winning our inaugural Innovation Awards, we caught up with Niclas Nilsson